The FDA approval of the MiniMed 780G artificial pancreas promises better glucose control in patients with type1diabetes, and Dr Ann Peters is 'excited' to use it with her patients. EndoTwitter
There is wonderful news in the field of hybrid closed-loop pump technology because the Medtronic 780G system. I can't tell you how happy this makes me because we've all been waiting for this seemingly forever and ever. This isn't just a small upgrade from the 770G. It's a quantum leap from the 770G to the 780G. The 780G has newer algorithms, a new sensor, and a longer-lasting infusion set.
First, it has something called meal-detection technology with autocorrection boluses every 5 minutes. If this works, it can be a huge win for our patients because the problem my patients have is with mealtime dosing. They often dose late, or they may not dose enoughAll these hybrid closed-loop systems, this one included, show that the best improvements in glycemia are overnight. I'm hoping that this one shows some nice improvements in daytime glycemia as well.
Finally, it has a new sensor. It looks like the old sensors, but it's the Guardian 4, which requires much fewer finger sticks. Now, I'm not entirely sure about how often one has to do a finger stick. I know one has to do with finger sticking to initiate auto mode, or what they call SmartGuard, but I don't know whether you ever have to do it again. I know for sure that you have to do it again if you fall out of the automated mode into manual mode.
I do know that preorders for this system, if you want to buy the new physical system, start on May 15. The shipping of the new 780G system, should occur in the United States toward the end of this summer.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Fast Tracks Potential CAR T-Cell Therapy for LupusThe cellular therapy depletes CD19-positive B cells with the goal of 'resetting' the immune system to achieve durable remission.
Read more »
FDA OKs Once-Nightly Sodium Oxybate for NarcolepsyExtended-release sodium oxybate (Lumryz) is taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
Read more »
Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant PatchXelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.
Read more »
The Newest FDA-Approved Neuromodulator Will Get Rid of 11-Lines for Six MonthsThis new Botox alternative promises results that last twice as long as its competitors. So—what do actual dermatologists think?
Read more »
US FDA declines to approve Ascendis' hormone disorder therapyAscendis Pharma A/S said on Monday the U.S. Food & Drug Administration had declined to approve the Danish drugmaker's experimental therapy to treat adult patients with a hormone disorder called hypoparathyroidism, citing concerns linked to manufacturing control of the drug and device combination.
Read more »
FDA Does Not Require Menstrual Product Ingredients on LabelsNew York and California have passed laws requiring disclosure of ingredients on menstrual product packaging. Advocates want more transparency across the United States.
Read more »